We speak with the BPSA to find out why X-ray sterilization is being considered as an alternative to gamma irradiation

In light of cabotegravir’s positive opinion for sexually acquired HIV-1, I wanted to explore the history and politics of HIV/AIDS drug development

Experts from Emergent BioSolutions break down the qualities that make an ideal CDMO partner for plasma- based protein manufacturing

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Could non-pathogenic viruses provide an unrejectable therapeutic target?

Lessons learned in starting up a company – and navigating an industry dominated by men.

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Sitting Down With Dick Sundh, General Manager, Kite Pharma

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.